Physicians Office Resource's authored articles and clinical reviews, alongside curated literature and news for practical point-of-care guidance and insight.
by Dr. Jay Long, MD, Retired Vascular Surgeon, Medical Director – Semler Scientific, Inc. A major lower-extremity amputation has been reported to be the most feared complication by patients experiencing diabetic foot problems. 1 The statistics surrounding diabetic foot ulcers (DFU) and potential subsequent amputations are staggering.
Part 2: Business Opportunities in Healthcare by Dr. Shakeel Ahmed Part 2 of a 6 Part Series For part 1 of this article please visit PhysiciansOfficeResource.com/articles “Success usually comes to those who are too busy to be looking for it.” — Henry David Thoreau After outlining the fundamental principles necessary for success in business in my initial article, this piece aims to provide an overview of the various healthcare business categories that a novice inve...
by Galit Gelman, Commercial Marketing Manager, SEKISUI Diagnostics Point-of-care diagnostics, particularly in molecular testing, face challenges related to accessibility and affordability. The complexity of molecular testing techniques requires specialized training for laboratory personnel, contributing to variations in test quality. Infrastructure requirements for well-equipped laboratories may hinder accessibility, especially in resource-limited settings. Delays in obtaining results can imp...
by Michael Baker, Staff Writer Physicians Office Resource I have a host of scars that I’ve acquired over the years. Truth be told, I don’t mind my scars. Each one comes with a different, sometimes funny, stupid, adventurous, or scary story. Not only do these scars carry memories, but they also represent triumph. To me is amazing to think each scar represents a time when my body failed but also shows how it was able to overcome that failure.
by Nitsan Maayan-Rabinowich, Chief Strategy Officer, Sight Diagnostics Whether you’re planning to establish a moderately complex Physician Office Lab, or you're an experienced practitioner eyeing a new Complete Blood Count (CBC) analyzer for your existing facility, understanding the key factors in selecting the right equipment is paramount. This article is designed to help you navigate the selection process of a CBC analyzer that will align seamlessly with your clinical demands and oper...
by David Kliff of the Diabetic Investor I doubt anyone would argue that we have seen major advancements in diabetes technology. Conventional fingerstick glucose monitors (BGM) while still around are being replaced by Continuous Glucose Monitoring Systems (CGM). Insulin pumps have become Automated Insulin Delivery systems using CGM and sophisticated insulin dosing algorithms which learn. Insulin pens once “dumb” devices have transformed into “smart” connected devices.
by Physicians Office Resource It’s estimated that an approximate 3 million adults in the United States have been diagnosed with inflammatory bowel disease (IBD). Of those 3 million, the most common forms of IBD include Ulcerative Colitis (UC) and Crohn’s Disease. In this article we’ll take a closer look at the similarities, differences, treatments and what you can do as a primary care physician to help your patients navigate their battle with these diseases.
Part 1: The Blueprint to Financial Riches in Healthcare by Dr. Shakeel Ahmed “ Do not wait to strike till the iron is hot; but make it hot by striking.” – William Butler Yeats This is the first of a 6-article series I will write on how to invest in healthcare, and strike gold in the business of medicine. This collection of writings will serve as a repository of guidance and schematics for those venturing into the realm of healthcare entrepreneurship. It aims to distill...
by Shakeel Ahmed, MD “The sustenance of private practice doctors, like the survival of small bakeries amidst the sprawling dominion of retail giants, nurtures a tapestry of diverse health care providers, ensuring that patients have access to a symphony of medical options in close proximity to their communities.” – Dr. Clarissa Meadowsong, patient advocate and champion of health care diversity.
by David Kliff of the Diabetic Investor It almost seems presumptuous to look beyond the current crop of drugs like Ozempic, Wegovy and Mounjaro. All three have patent protection well into the next decade, sales continue to skyrocket plus Novo Nordisk and Eli Lilly have robust pipelines of follow on products. This is a huge and growing market that is vastly underpenetrated. Still, it would be foolish not to look ahead, as Novo and Lilly aren’t the only companies who want to play in this...
by Aaron Medaris Gene therapy, a groundbreaking field in medical science, holds the promise of revolutionizing the way we treat and potentially cure a wide range of genetic disorders. This innovative approach involves the introduction, alteration, or replacement of genetic material within a patient's cells to correct or eliminate the root cause of a disease. Over the past few decades, gene therapy has evolved from a theoretical concept to a rapidly advancing field with significant clinical im...
by David Kliff of the Diabetic Investor Think about this just for a moment. When was the last time a patient walked into your office and practically demanded that you put them on a drug? When was the last time these same patients said, “cost be damned, I don’t care that it’s going to cost me over $1,000 a month. I want to be on this drug.” How often do these patients give you the I really don’t care look when you explain this is a diabetes drug, they don’t have diabetes, and as good as these...
